Table 2.
HAL fluorescence group, n=365 (ITT Detection) | ||
---|---|---|
| ||
Total, n (% of patients in the ITT Detection group with stated tumor type) | Patients with at least one lesion of each type detected only with fluorescence | |
Patients with Ta or T1 tumors | 286 (78.4%) | 47 (16.4%) (95% CI: 12.3 – 21.2)% |
Patients with Ta tumors | 262 (71.8%) | 41 (15.6%) |
Patients with T1 tumors | 63 (17.3%) | 8 (12.7%) |
Patients with CIS | 41 (11.2%) | 19 (46.3%) |
Note: patients may have more than one tumor type